For many years, delivering drug molecules across the blood brain barrier has been a major
challenge. The neuropeptide nerve growth factor is involved in the regulation of growth and …

Background Our previous studies suggest that human fat extract (FE) contains a variety of
angiogenic factors and may provide an alternative treatment option for stroke. However, the …

Here, we describe a nanocarrier system that can transfer chitosan nanoparticles loaded with
either small peptides such as the caspase inhibitor Z-DEVD-FMK or a large peptide like …

Therapies against stroke can restore the blood supply but cannot prevent the ischemic
damage nor stimulate the recovery of the infarcted zone. The neuroglobin protein plays an …

Stroke is a global health and socio-economic problem. However, no efficient preventive
and/or palliative treatments have yet been found. Neuroglobin (Ngb) is an endogen …

Although growth factors and anti-apoptotic peptides have been shown to be neuroprotective
in stroke models, translation of these experimental findings to clinic is hampered by limited …

Microfluidic-based nanoscale drug delivery systems have risen to prominence in the field of
precision nanomedicine in recent years. This intriguing innovation could provide unique …

Stroke is the leading neurological cause of death and disability all over the world, with few
effective drugs. Nerve growth factor (NGF) is well known for its multifaceted neuroprotective …

Here, we describe a nanocarrier system that can transfer chitosan nanoparticles loaded with
either small peptides such as the caspase inhibitor Z-DEVD-FMK or a large peptide like …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with
amyloid-β peptide misfolding and aggregation. Neurotrophic factors, such as nerve growth …